Esther A. Ubick

Effect of Dietary Constituents With Chemopreventive Potential on Adduct Formation of a Low Dose of the Heterocyclic Amines PhIP and IQ and Phase II Hepatic Enzymes

Karen H. Dingley, Esther A. Ubick, Marina L. Chiarappa-Zucca et al. · Nutrition and Cancer · 2003 · 96 citations

Pharmacy, Pharmacology, Toxicology +13

Inflammation and Atrophy Precede Prostatic Neoplasia in a PhIP-Induced Rat Model

Alexander D. Borowsky, Karen H. Dingley, Esther A. Ubick et al. · Neoplasia · 2006 · 68 citations · Full text

Medicine, Pathology, Toxicology +17

The Urinary Metabolite Profile of the Dietary Carcinogen 2-Amino-1-Methyl-6-Phenylimidazo[4,5-<i>b</i>]Pyridine Is Predictive of Colon DNA Adducts after a Low-Dose Exposure in Humans

Michael Malfatti, Karen H. Dingley, Susan Nowell-Kadlubar et al. · Cancer Research · 2006 · 68 citations · Full text

Pharmacy, Pharmacology, Toxicology +17

EVALUATION OF MICRODOSING STRATEGIES FOR STUDIES IN PRECLINICAL DRUG DEVELOPMENT: DEMONSTRATION OF LINEAR PHARMACOKINETICS IN DOGS OF A NUCLEOSIDE ANALOG OVER A 50-FOLD DOSE RANGE

Punam Sandhu, John S. Vogel, Mark J. Rose et al. · Drug Metabolism and Disposition · 2004 · 65 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +16

Dose-Response Relationships for<i>N</i>7-(2-Hydroxyethyl)Guanine Induced by Low-Dose [14C]Ethylene Oxide: Evidence for a Novel Mechanism of Endogenous Adduct Formation

Debbie A. Marsden, Donald J. L. Jones, Robert G. Britton et al. · Cancer Research · 2009 · 40 citations · Full text

Pharmacy, Molecular Biology, Toxicology +16